FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2955547682> ?p ?o ?g. }

• W2955547682 endingPage "152" @default.
• W2955547682 startingPage "146" @default.
• W2955547682 abstract "Abstract Objectives aPL are present in between 20 and 30% of patients with SLE. They can cause vascular events (VE) or pregnancy morbidity. aCL and anti-beta-2-glycoprotein I (anti-β2GPI) are measured in clinical practice. Domain I (DI) of β2GPI is the main site for aPL binding. We investigated the prevalence of IgG anti-DI, aCL and anti-β2GPI antibodies in early SLE and their association with mortality and development of VE. Methods Samples from 501 patients with SLE that had been obtained and stored early during their disease were tested for IgG anti-DI, aCL and anti-β2GPI antibodies by ELISA. LA status and history of VE were obtained by reviewing medical records. Kaplan–Meier analysis was used to investigate mortality and occurrence of VE, comparing groups with and without aPL in early disease. Results Of 501 patients, 190 (38%) had at least one of these aPL, of whom 112 had anti-DI alone. Of 276 patients with complete vascular history, 83 had experienced VE. The 39 patients who were double or triple-ELISA-positive for any combination of the three aPL were more likely to have or develop lupus anticoagulant (P&lt;0.0001) than those who were single-ELISA-positive or negative. In Kaplan–Meier analysis, they showed a trend towards developing more VE (P = 0.06). Conclusion IgG anti-DI antibodies were present in early serum samples from 29% of patients and were more common than IgG aCL or anti-β2GPI. There was some evidence suggesting that double or triple-ELISA-positivity for these antibodies identified a group with worse outcomes." @default.
• W2955547682 created "2019-07-12" @default.
• W2955547682 creator A5013104655 @default.
• W2955547682 creator A5024237017 @default.
• W2955547682 creator A5024384780 @default.
• W2955547682 creator A5033602979 @default.
• W2955547682 creator A5057606320 @default.
• W2955547682 creator A5057848962 @default.
• W2955547682 creator A5065798696 @default.
• W2955547682 creator A5091574164 @default.
• W2955547682 date "2019-06-30" @default.
• W2955547682 modified "2023-10-16" @default.
• W2955547682 title "Antiphospholipid antibody levels in early systemic lupus erythematosus: are they associated with subsequent mortality and vascular events?" @default.
• W2955547682 cites W1992325618 @default.
• W2955547682 cites W1996433458 @default.
• W2955547682 cites W2006745686 @default.
• W2955547682 cites W2010874397 @default.
• W2955547682 cites W2011021023 @default.
• W2955547682 cites W2054330426 @default.
• W2955547682 cites W2058189064 @default.
• W2955547682 cites W2069797332 @default.
• W2955547682 cites W2070527591 @default.
• W2955547682 cites W2078610240 @default.
• W2955547682 cites W2101326680 @default.
• W2955547682 cites W2119085128 @default.
• W2955547682 cites W2119266650 @default.
• W2955547682 cites W2132103149 @default.
• W2955547682 cites W2160597832 @default.
• W2955547682 cites W2416636197 @default.
• W2955547682 cites W2440701858 @default.
• W2955547682 cites W2589187715 @default.
• W2955547682 cites W2792087609 @default.
• W2955547682 cites W2885614240 @default.
• W2955547682 cites W2898011957 @default.
• W2955547682 cites W2899593773 @default.
• W2955547682 doi "https://doi.org/10.1093/rheumatology/kez239" @default.
• W2955547682 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6909892" @default.
• W2955547682 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31257438" @default.
• W2955547682 hasPublicationYear "2019" @default.
• W2955547682 type Work @default.
• W2955547682 sameAs 2955547682 @default.
• W2955547682 citedByCount "11" @default.
• W2955547682 countsByYear W29555476822020 @default.
• W2955547682 countsByYear W29555476822021 @default.
• W2955547682 countsByYear W29555476822022 @default.
• W2955547682 countsByYear W29555476822023 @default.
• W2955547682 crossrefType "journal-article" @default.
• W2955547682 hasAuthorship W2955547682A5013104655 @default.
• W2955547682 hasAuthorship W2955547682A5024237017 @default.
• W2955547682 hasAuthorship W2955547682A5024384780 @default.
• W2955547682 hasAuthorship W2955547682A5033602979 @default.
• W2955547682 hasAuthorship W2955547682A5057606320 @default.
• W2955547682 hasAuthorship W2955547682A5057848962 @default.
• W2955547682 hasAuthorship W2955547682A5065798696 @default.
• W2955547682 hasAuthorship W2955547682A5091574164 @default.
• W2955547682 hasBestOaLocation W29555476821 @default.
• W2955547682 hasConcept C10515644 @default.
• W2955547682 hasConcept C126322002 @default.
• W2955547682 hasConcept C159654299 @default.
• W2955547682 hasConcept C195910791 @default.
• W2955547682 hasConcept C203014093 @default.
• W2955547682 hasConcept C2776670291 @default.
• W2955547682 hasConcept C2776874634 @default.
• W2955547682 hasConcept C2777466421 @default.
• W2955547682 hasConcept C2778674544 @default.
• W2955547682 hasConcept C2779075594 @default.
• W2955547682 hasConcept C2779134260 @default.
• W2955547682 hasConcept C2779234561 @default.
• W2955547682 hasConcept C2780022809 @default.
• W2955547682 hasConcept C2781179581 @default.
• W2955547682 hasConcept C50382708 @default.
• W2955547682 hasConcept C54355233 @default.
• W2955547682 hasConcept C71924100 @default.
• W2955547682 hasConcept C86803240 @default.
• W2955547682 hasConcept C90924648 @default.
• W2955547682 hasConceptScore W2955547682C10515644 @default.
• W2955547682 hasConceptScore W2955547682C126322002 @default.
• W2955547682 hasConceptScore W2955547682C159654299 @default.
• W2955547682 hasConceptScore W2955547682C195910791 @default.
• W2955547682 hasConceptScore W2955547682C203014093 @default.
• W2955547682 hasConceptScore W2955547682C2776670291 @default.
• W2955547682 hasConceptScore W2955547682C2776874634 @default.
• W2955547682 hasConceptScore W2955547682C2777466421 @default.
• W2955547682 hasConceptScore W2955547682C2778674544 @default.
• W2955547682 hasConceptScore W2955547682C2779075594 @default.
• W2955547682 hasConceptScore W2955547682C2779134260 @default.
• W2955547682 hasConceptScore W2955547682C2779234561 @default.
• W2955547682 hasConceptScore W2955547682C2780022809 @default.
• W2955547682 hasConceptScore W2955547682C2781179581 @default.
• W2955547682 hasConceptScore W2955547682C50382708 @default.
• W2955547682 hasConceptScore W2955547682C54355233 @default.
• W2955547682 hasConceptScore W2955547682C71924100 @default.
• W2955547682 hasConceptScore W2955547682C86803240 @default.
• W2955547682 hasConceptScore W2955547682C90924648 @default.
• W2955547682 hasFunder F4320334626 @default.
• W2955547682 hasIssue "1" @default.
• W2955547682 hasLocation W29555476821 @default.
• W2955547682 hasLocation W29555476822 @default.

• next